Department of Surgery

T32 - Vascular Surgery Training Grant

Vascular Surgery Training Grant

Program Director: Edith Tzeng MD

This research training program in the Division of Vascular Surgery, funded by the National Institute of General Medical Sciences (NIGMS), is in its 3rd year and provides interdisciplinary laboratory training for up to six surgical residents or postdoctoral fellows with MD and/or PhD qualifications. Available projects include research studies relevant to endothelial and stem cell biology, nitric oxide biology and vascular and cutaneous wound healing. Read more about current projects on our general surgery/vascular labs research page.

Eligibility

Individuals with a MD, MD/PhD, or PhD must also be U.S. citizens or permanent residents. Applicants should be prepared to make a commitment of two to three years of training dedicated to full-time research.

Trainees are expected to actively participate in research seminars, journal clubs, RCR training and laboratory meetings. Trainees are also encouraged to present their work at local and national meetings. Our training program provides trainees with the basic knowledge and required skills to enable them to function successfully as independent investigators. Financial support includes stipends, medical insurance, travel and other training-related expenses.

We seek to reflect our community with regard to gender, culture and life experiences, age, disability, race, ethnicity, geography, religion, sexual orientation and socioeconomic status. Diversity strengthens our institution by increasing talent and ensuring a fuller perspective. For further information on diversity programs at the University of Pittsburgh please visit the following websites:

To Apply

Please send a cover letter and resume via either email or mail to:

Kathy DiGiacomo
University of Pittsburgh
Department of Surgery Labs
NW607 MUH
3459 Fifth Avenue
Pittsburgh, PA 15213

Training Faculty

Edith Tzeng, MD

Translational studies of carbon monoxide and nitric oxide in intimal hyperplasia, angiogenesis, and wound healing, stem cell treatment of critical limb ischemia

Efthymios D. Avgerinos, MD, PhD, MSc

Carotid artery disease, critical limb ischemia, venous disease and pulmonary embolism interventions

Timothy R. Billiar, MD

Mechanisms leading to the activation of the innate immune system and associated immune dysfunction following injury

Rabih Chaer, MD

Endovascular interventions, venous interventions

Alex Chen, MD, PhD

Cell and gene therapy on vascular injuries and regeneration

Bruce Freeman, PhD

Nitric oxide and nitrated fatty acids

Mark Gladwin, MD

Pulmonary hypertension and pulmonary complications of sickle cell disease

Thomas Gleason, MD, MS

Etiology of thoracic aortic aneurysm disease

Johnny Huard, PhD

Expand the possibilities of tissue engineering by unlocking the potential of gene therapy and adult stem cell research and transferring research findings into the development of effective treatments for damaged or diseased tissues as they relate to the musculoskeletal system

Jeffrey Isenberg, MD, MPH

Regulatory molecular events that act through the nitric oxide pathway to regulate blood flow and pressure as well as cardiac function in both the right and left sides of the circulation, mechanisms to enhance tissue blood flow, perfusion, and wound healing.

Michel S. Makaroun, MD

Outcomes and comparative effectiveness, evaluation of vascular technology

Kacey Marra, PhD

Adipose-derived stem cells, tissue engineering, nerve regeneration, soft tissue reconstruction, wound healing

Larissa Myaskovsky, PhD

Health services research and disparities in healthcare processes and outcomes

Julie Phillippi, PhD

Extracellular matrix and its role in vascular wall biology

Bruce Pitt, PhD

Pulmonary vascular biology

Steven Reis, MD

Pathophysiological mechanisms for atherosclerosis, racial and gender disparities in CVD, clinical and translational research

Mark Roberts, MD

Decision sciences, cost effectiveness and health services research

Matthew R. Rosengart, MD, MPH

Inflammation during sepsis/critical illness; trauma system organization and infrastructure

Ulka Sachdev, MD

Role of HMGB-1 and innate immune receptors in promoting angiogenesis after ischemic injury

Jason L. Sperry, MD, MPH

Trauma, sex-based outcome differences; coagulopathy, hemorrhage control

Bryan Tillman, MD, PhD

Stem cell and biomaterial design; innovative vascular devices for the control of hemorrhage

Flordeliza S. Villaneuva, MD

Cardiovascular imaging

David A. Vorp, PhD

Mechanopathobiological assessment of abdominal and thoracic aortic aneurysm, development of a human stem cell-based tissue engineered vascular graft, mechanical characterization of cerebral aneurysms

Simon Watkins, PhD

Optical imaging and application to the study of basic cell biology and inflammation

William Wagner, PhD

Cardiovascular tissue engineering and medical device biocompatibility and design

Alan Wells, PhD

Mechanisms of cell migration, wound healing and organogenesis

Theodore Yuo, MD, MS

Clinical decision making in the setting of hemodialysis access

Brian Zuckerbraun, MD

The acute inflammatory response in the liver and vasculature following injury from trauma/hemorrhagic shock, sepsis, or direct vascular injury